These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 214498)

  • 1. Mechanisms of action of "lymphocyte-activating factor" (LAF). III. Evidence that LAF acts on stimulated lymphocytes by raising cyclic GMP in G1.
    Katz SP; Kierszenbaum F; Waksman BH
    J Immunol; 1978 Dec; 121(6):2386-91. PubMed ID: 214498
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of action of 'lymphocyte activating factor' (LAF) I. Association of lymphocyte activating factor action with early DNA synthesis in PHA-stimulated lymphocytes.
    Kiertdzenbaum F; Waksman BH
    Immunology; 1977 Nov; 33(5):663-9. PubMed ID: 590994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of action of "lymphocyte activating factor" (LAF)--II. LAF effect is resistant to elevation of cellular cyclic AMP.
    Kierszenbaum F; Waksman BH
    Immunochemistry; 1978 Nov; 15(10-11):807-11. PubMed ID: 218885
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulatory substances produced by lymphocytes. VIII. Cell cycle specificity of inhibitor of DNA synthesis (IDS) action in lymphocytes.
    Wagshal AB; Waksman BH
    J Immunol; 1978 Sep; 121(3):966-72. PubMed ID: 211168
    [No Abstract]   [Full Text] [Related]  

  • 5. Concanavalin A and the initiation of thymic lymphoblast DNA synthesis and proliferation by a calcium-dependent increase in cyclic GMP level.
    Whitfield JF; MacManus JP; Boynton AL; Gillan DJ; Isaacs RJ
    J Cell Physiol; 1974 Dec; 84(3):445-58. PubMed ID: 4373488
    [No Abstract]   [Full Text] [Related]  

  • 6. Two distinct lumphocyte-stimulating soluble factors (LAF) released from murine peritoneal cells. I. The cellular source and the effect of cGMP on their release.
    Diamantstein T; Ulmer A
    Immunology; 1976 May; 30(5):741-7. PubMed ID: 179941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for cyclic GMP and calcium mediation of lymphocyte activation by mitogens.
    Coffey RG; Hadden EM; Hadden JW
    J Immunol; 1977 Oct; 119(4):1387-94. PubMed ID: 197170
    [No Abstract]   [Full Text] [Related]  

  • 8. [Regulation of the cell cycle of B-lymphocytes in mice by substances elevating the levels of intracellular cAMP and cGMP].
    Ado AD; Dontsov VI; Gol'dshteĭn MM
    Biull Eksp Biol Med; 1985 Apr; 99(4):455-8. PubMed ID: 2985157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous pyrogens made by rabbit peritoneal exudate cells are identical with lymphocyte-activating factors made by rabbit alveolar macrophages.
    Murphy PA; Simon PL; Willoughby WF
    J Immunol; 1980 May; 124(5):2498-501. PubMed ID: 6965973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonspecific "lymphocyte activating" factors produced by macrophages.
    Diamantstein T; Oppenheim JJ; Unanue ER; Wood DD; Handschumacher RE; Rosenstreich DL; Waksman BH
    Clin Immunol Immunopathol; 1979 Oct; 14(2):264-7. PubMed ID: 226303
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS.
    Mizel SB; Oppenheim JJ; Rosentreich DL
    J Immunol; 1978 May; 120(5):1504-8. PubMed ID: 307016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic nucleotides and calcium in human lymphocytes induced to divide.
    Rochette-Egly C; Kempf J
    J Physiol (Paris); 1981 Sep; 77(6-7):721-5. PubMed ID: 6270320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic AMP and the immune response;
    Parker CW; Sullivan TJ; Wedner HJ
    Adv Cyclic Nucleotide Res; 1974; 4(0):1-79. PubMed ID: 4368552
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurotransmitters, hormones, and cyclic nucleotides in lymphocyte regulation.
    Coffey RG; Hadden JW
    Fed Proc; 1985 Jan; 44(1 Pt 1):112-7. PubMed ID: 2857137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic AMP and calcium as intracycle regulators in the control of cell proliferation.
    MacManus JP; Boynton AL; Whitfield JF
    Adv Cyclic Nucleotide Res; 1978; 9():485-91. PubMed ID: 208391
    [No Abstract]   [Full Text] [Related]  

  • 17. [The cellular immune system. Possible adverse effects of drugs].
    Bruserud O
    Tidsskr Nor Laegeforen; 1986 Aug; 106(24):1939-40, 1951. PubMed ID: 3022416
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms by which oxidative injury inhibits the proliferative response of human lymphocytes to PHA. Effect of the thiol compound 2-mercaptoethanol.
    Gougerot-Pocidalo MA; Fay M; Roche Y; Chollet-Martin S
    Immunology; 1988 Jun; 64(2):281-8. PubMed ID: 3391643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of human leukocyte migration inhibitory factor (LIF) by lymphocytes stimulated with phytohemagglutinin. II. Effects of cyclic nucleotides.
    Bendtzen K; Mahoney R; Rocklin RE
    Clin Immunol Immunopathol; 1981 Feb; 18(2):221-9. PubMed ID: 6258834
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cyclic nucleotide levels in activated human T lymphocytes].
    Komissarenko SV
    Ukr Biokhim Zh (1978); 1988; 60(3):30-4. PubMed ID: 2842905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.